Can’t sleep for thinking about the Surgcenter deal.
They get a 10% interest in our company for US$110m, they become shareholders just like us with the same desire to see the company succeed.
Their primary business is in fixing bad backs. It just so happens that Mesoblast is in the business of providing stem cells for lower back pain. How fortuitous! Coincidence? I don’t think so.
We then find that Surgcenter is also in the business of treating heart failure incidents. It also just so happens that Mesoblast is in the business of supplying stem cells to treat chronic heart failure. Again, how fortuitous!
l think the snorters realise the synergies here, and are redoubling their efforts with their flunkies to
put about as much poison as they can to suppress the share price while they exit their positions.
Think there’s gunna be a rerate?
That’s enough now, think I’ll try counting sheep . .
The investment case FOR Mesoblast, page-95
-
- There are more pages in this discussion • 328 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |